Testing improved genetic screening for fertility treatment
Part of Women’s health & pregnancy clinical trials.
This study tests an upgraded method to screen embryos for genetic abnormalities before implantation during fertility treatment. It may help couples with age-related fertility concerns, repeated implantation failures, recurrent miscarriages, or male factor infertility achieve successful pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 35 years old, OR have experienced repeated implantation failures, OR have had recurrent miscarriages, OR have severe male factor infertility
- You have at least one viable embryo (blastocyst) available from your fertility cycle
- You do not have structural chromosomal abnormalities (like balanced translocations) that you or your partner carry
- You are not using donated eggs or sperm for this cycle
- You do not have untreated uterine abnormalities or blocked fallopian tubes that would prevent pregnancy
- You are medically able to become pregnant and undergo fertility treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This study looks at embryo health using a DNA test called PGT-A for couples having IVF. It may help researchers better understand what the test can and cannot tell about which embryos are healthiest.
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
This study tests embryos before pregnancy using genetic screening to look for extra or missing chromosomes, in people who have had repeated IVF embryo transfers without success. It may help reduce the chance of transferring embryos that are unlikely to result in a healthy pregnancy.
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
This study looks at using embryo genetic testing before pregnancy in IVF for women aged 35 to 40. It may help by identifying which embryos are more likely to lead to a healthy pregnancy, though you would still be screened to confirm you fit the criteria.
Hear when a new Infertility Assisted Reproductive Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.